Sirtris Pharmaceuticals said that it's CEO, Christoph Westphal, has been named the Ernst & Young New England Entrepreneur of the Year in the biopharmaceutical field.
Westphal is a co-founder of Alnylam Pharmaceuticals, and previously was a partner at Alnylam investor Polaris Venture Partners.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
